HTR2C promoter polymorphisms are associated with risperidone efficacy in Chinese female patients.
Liu, Bao-Cheng; Zhang, Jing; Wang, Lei; Li, Xing-Wang; Wang, Yang; Wei, Zhi-Yun; Ji, Jue; Yang, Feng-Ping; Wan, Chun-Ling; Xu, Yi-Feng; Feng, Guo-Yin; He, Lin; He, Guang.
; 11(5): 685-92, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20415561
Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia.
Comparing the influence of dopamine D2 polymorphisms and plasma drug concentrations on the clinical response to risperidone.
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
Paliperidone palmitate for schizophrenia.
Sertindole versus other atypical antipsychotics for schizophrenia.
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Risperidone for autism spectrum disorder.
Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.